NO20072720L - Farmasoytiske sammensetninger basert pa NK2-antagonister for pediatrisk bruk - Google Patents

Farmasoytiske sammensetninger basert pa NK2-antagonister for pediatrisk bruk

Info

Publication number
NO20072720L
NO20072720L NO20072720A NO20072720A NO20072720L NO 20072720 L NO20072720 L NO 20072720L NO 20072720 A NO20072720 A NO 20072720A NO 20072720 A NO20072720 A NO 20072720A NO 20072720 L NO20072720 L NO 20072720L
Authority
NO
Norway
Prior art keywords
antagonists
pharmaceutical compositions
compositions based
pediatric use
pediatric
Prior art date
Application number
NO20072720A
Other languages
English (en)
Other versions
NO338586B1 (no
Inventor
Carlo Alberto Maggi
Maria Altamura
Alberto Aleotti
Original Assignee
Guidotti & C Spa Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guidotti & C Spa Labor filed Critical Guidotti & C Spa Labor
Publication of NO20072720L publication Critical patent/NO20072720L/no
Publication of NO338586B1 publication Critical patent/NO338586B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/451Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Farmasøytisk sammensetning inneholdende NK2-antagonister er beskrevet, anvendelige for behandlingen av spedbamskolikk.
NO20072720A 2004-10-27 2007-05-29 Anvendelse av tachykininantagonist for fremstilling av farmasøytiske formuleringer, oral farmasøytisk sammensetning for pediatrisk anvendelse, og matprodukt omfattende nevnte farmasøytiske sammensetning NO338586B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000221A ITFI20040221A1 (it) 2004-10-27 2004-10-27 Composizioni farmaceutiche a base di nk2 antagonisti per uso pediatrico
PCT/EP2005/055575 WO2006045820A1 (en) 2004-10-27 2005-10-26 Pharmaceutical compositions based on nk2 antagonists for pediatric use

Publications (2)

Publication Number Publication Date
NO20072720L true NO20072720L (no) 2007-07-09
NO338586B1 NO338586B1 (no) 2016-09-12

Family

ID=35613882

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072720A NO338586B1 (no) 2004-10-27 2007-05-29 Anvendelse av tachykininantagonist for fremstilling av farmasøytiske formuleringer, oral farmasøytisk sammensetning for pediatrisk anvendelse, og matprodukt omfattende nevnte farmasøytiske sammensetning

Country Status (26)

Country Link
US (2) US7727955B2 (no)
EP (1) EP1809267B1 (no)
JP (1) JP2008517977A (no)
CN (1) CN101052386A (no)
AR (1) AR051595A1 (no)
AT (1) ATE422881T1 (no)
AU (1) AU2005298629B2 (no)
CA (1) CA2584481C (no)
CY (1) CY1109803T1 (no)
DE (1) DE602005012857D1 (no)
DK (1) DK1809267T3 (no)
EA (1) EA012264B1 (no)
ES (1) ES2325413T3 (no)
HK (1) HK1109335A1 (no)
HR (1) HRP20090225T1 (no)
IT (1) ITFI20040221A1 (no)
MX (1) MX2007004461A (no)
NO (1) NO338586B1 (no)
NZ (1) NZ555380A (no)
PL (1) PL1809267T3 (no)
PT (1) PT1809267E (no)
RS (1) RS50780B (no)
SI (1) SI1809267T1 (no)
UA (1) UA91988C2 (no)
WO (1) WO2006045820A1 (no)
ZA (1) ZA200703909B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0614970D0 (en) * 2006-07-27 2006-09-06 R & D Sosei Ltd Compounds For Use In Therapy
IT1394304B1 (it) * 2009-05-21 2012-06-06 Malesci Sas Processo per la preparazione di ibodutant (men15596) e relativi intermedi
ITRM20120331A1 (it) * 2012-07-12 2014-01-13 Guidotti & C Spa Labor Composizioni pediatriche orali liquide contenenti nepadutant.
US20160051596A1 (en) * 2014-08-21 2016-02-25 Food Industry Research And Development Institute Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9867857B2 (en) 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0219318A (ja) * 1988-06-30 1990-01-23 Carl R Thornfeldt 疝痛及び生歯に対する治療
IT1277835B1 (it) * 1995-03-13 1997-11-12 Menarini Farma Ind Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
IT1307809B1 (it) * 1999-10-21 2001-11-19 Menarini Ricerche Spa Composti monociclici basici ad azione nk-2 antagonista, processi difabbricazione e formulazioni che li contengono.
MY130373A (en) * 2001-10-29 2007-06-29 Malesci Sas Linear basic compounds having nk-2 antagonist activity and formulations thereof
GB0224788D0 (en) * 2002-10-24 2002-12-04 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
EP1809267B1 (en) 2009-02-18
EA012264B1 (ru) 2009-08-28
EP1809267A1 (en) 2007-07-25
PT1809267E (pt) 2009-05-28
US7727955B2 (en) 2010-06-01
MX2007004461A (es) 2007-07-11
CN101052386A (zh) 2007-10-10
HK1109335A1 (en) 2008-06-06
ZA200703909B (en) 2008-09-25
NO338586B1 (no) 2016-09-12
WO2006045820A1 (en) 2006-05-04
NZ555380A (en) 2008-12-24
EA200700949A1 (ru) 2007-10-26
PL1809267T3 (pl) 2009-07-31
ES2325413T3 (es) 2009-09-03
JP2008517977A (ja) 2008-05-29
AU2005298629A1 (en) 2006-05-04
HRP20090225T1 (en) 2009-05-31
RS50780B (sr) 2010-08-31
US20100234284A1 (en) 2010-09-16
CY1109803T1 (el) 2014-09-10
ITFI20040221A1 (it) 2005-01-27
UA91988C2 (ru) 2010-09-27
DK1809267T3 (da) 2009-05-18
AU2005298629B2 (en) 2011-02-17
DE602005012857D1 (de) 2009-04-02
US20080090795A1 (en) 2008-04-17
CA2584481C (en) 2014-07-15
AR051595A1 (es) 2007-01-24
ATE422881T1 (de) 2009-03-15
SI1809267T1 (sl) 2009-06-30
CA2584481A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
CY1110965T1 (el) Επιπροσθετες ετεροπολυκυκλικες ενωσεις και η χρηση τους ως ανταγωνιστες μεταβολοτροπικου υποδοχεα γλουταμικου
CY1111702T1 (el) Τα παραγωγα ινδολης ως αγωνιστες υποδοχεων s1p1
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
TW200612936A (en) Indole derivatives
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
SE0301700D0 (sv) Novel compounds
GEP20156348B (en) Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
DE602006006712D1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
IS8503A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
EA200700118A1 (ru) Амидосоединения и их применение в качестве лекарственных средств
MX2007011695A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
MX2009007104A (es) Derivados de oxindol sustituido y su uso como ligandos del receptor de vasopresina.
NO20070855L (no) Arylidener for behandling av estrogenrelaterte reseptor-alfamedierte sykdommer.
UA94600C2 (en) Indole sulfonamide modulators of progesterone receptors
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
EA200801997A1 (ru) Новые соединения
DK1730147T3 (da) Substituerede 1,4,8-triazaspiro[4.5]decan-2-on-forbindelser til behandling af fedme
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
UA96277C2 (en) Benzimidazole derivatives
ATE466842T1 (de) 3-substituierte pyridinderivate als h3- antagonisten
TW200637817A (en) 5-aminoindole derivatives
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees